TECX · Tectonic Therapeutic, Inc. · Executive Compensation
$21.04
+0.00 (+0.00%)
At close · Nov 19
Return incl. dividend (before tax)
Market Cap
$419.71M
Shares
19.95M
Volume · Nov 19
87.18K
Avg daily vol (3M)
210.71K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Alise Reicin | President, CEO and Director | $7,351,578 |
| Daniel Lochner | M.B.A. Chief Financial Officer | $3,101,114 |
| Marcella K. Ruddy | Chief Medical Officer | $3,069,630 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Alise Reicin | President, CEO and Director | $5,900,979 |
| Daniel Lochner | M.B.A. Chief Financial Officer | $2,284,007 |
| Marcella K. Ruddy | Chief Medical Officer | $1,840,892 |
| Erik Ostrowski | M.B.A. Former President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $1,093,258 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Erik Ostrowski | M.B.A. Former President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $1,590,892 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Geoff MacKay | Former President and Chief Executive Officer | $2,037,292 |
| Erik Ostrowski | President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $1,352,093 |
| Azadeh Golipour | Chief Technology Officer | $1,026,038 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Geoff MacKay | Former President and Chief Executive Officer | $5,363,022 |
| Christopher Mason | Chief Scientific Officer | $2,736,744 |
| Erik Ostrowski | President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $2,705,607 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Geoff MacKay | President and Chief Executive Officer | $4,904,395 |
| Birgitte Volck | M.D., Ph.D. Former President of R&D | $2,397,398 |
| Erik Ostrowski | Chief Financial Officer and Treasurer | $2,010,017 |
| Steven Avruch | Chief Legal Officer and Secretary | $1,766,976 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Erik Ostrowski | Chief Financial Officer and Treasurer | $2,753,795 |
| Geoff MacKay | President and Chief Executive Officer | $1,816,378 |
| Steven Avruch | Chief Legal Officer and Secretary | $1,384,377 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Geoff MacKay | President and Chief Executive Officer | $2,866,434 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Terrance McGuire | Chair of the Board | Resigned | 2026-02-24 |
| François Nader | Chair of the Board | Appointed | 2026-02-24 |
| François Nader | member of the Board | Appointed | 2026-02-24 |
| Dr. Christian Cortis | Chief Operating Officer | Terminated | 2024-07-05 |
| Marc Schwabish | Chief Business Officer | Appointed | 2024-06-20 |
| Marcella K. Ruddy | Chief Medical Officer | Appointed | 2024-06-20 |
| Peter McNamara | Chief Scientific Officer | Appointed | 2024-06-20 |
| Christian Cortis | Chief Operating Officer | Appointed | 2024-06-20 |
| Azadeh Golipour | all of their offices with AVROBIO and all of its subsidiaries | Resigned | 2024-06-20 |
| Essra Ridha | all of their offices with AVROBIO and all of its subsidiaries | Resigned | 2024-06-20 |
| Alise Reicin | Chief Executive Officer and principal executive officer | Appointed | 2024-06-20 |
| Steven Avruch | all of their offices with AVROBIO and all of its subsidiaries | Resigned | 2024-06-20 |
| Marcella K. Ruddy, M.D. | Chief Medical Officer | Appointed | 2024-06-20 |
| Marc Schwabish, Ph.D. | Chief Business Officer | Appointed | 2024-06-20 |
| Christian Cortis, Ph.D. | Chief Operating Officer | Appointed | 2024-06-20 |
| Daniel Lochner | Chief Financial Officer and principal financial officer and principal accounting officer | Appointed | 2024-06-20 |
| Peter McNamara, Ph.D. | Chief Scientific Officer | Appointed | 2024-06-20 |
| Alise Reicin, M.D. | Chief Executive Officer and principal executive officer | Appointed | 2024-06-20 |
| Erik Ostrowski | President, Interim Chief Executive Officer and Chief Financial Officer (principal executive officer, principal financial officer | Resigned | 2024-06-20 |
| Phillip B. Donenberg | member of the board of directors | Appointed | 2024-06-20 |
| Stefan Vitorovic, M.S., M.B.A. | member of the board of directors | Appointed | 2024-06-20 |
| Praveen Tipirneni, M.D. | member of the board of directors | Appointed | 2024-06-20 |
| Terrance McGuire | member of the board of directors | Appointed | 2024-06-20 |
| Timothy A. Springer, Ph.D. | member of the board of directors | Appointed | 2024-06-20 |
|
Bruce Booth, D.Phil.
“In accordance with the Merger Agreement, immediately prior to the Merger, Gail Farfel, Ph.D., Christopher Paige, Ph.D., Philip J. Vickers, Ph.D., Ian Clark, Annalisa Jenkins, M.B.B.S., F.R.C.P. and Bruce Booth, D.Phil. resigned from the AVROBIO's board of directors and committees of the AVROBIO board of directors on which they respectively served, which resignations were not the result of any disagreements with the Company relating to its operations, policies or practices.”
|
member of the board of directors | Resigned | 2024-06-20 |
Leadership
- Alise Reicin CEO, Board Member
- Alise Reicin, M.D. CEO, Board Member
- Erik Ostrowski CEO
- François Nader Chairman, Board Member
- Daniel Lochner CFO
- Christian Cortis COO
- Christian Cortis, Ph.D. COO
- Azadeh Golipour CTO
- Peter McNamara CTO
- Peter McNamara, Ph.D. CTO
- Jessica Chutter Board Member
- Phillip B. Donenberg Board Member
- Praveen Tipirneni, M.D. Board Member
- Stefan Vitorovic, M.S., M.B.A. Board Member
- Terrance McGuire Board Member
- Timothy A. Springer, Ph.D. Board Member
Key facts
CIK
1681087
CUSIP
878972108
13F (30d)
116 filings
110 filers
Visit website
Investor relations